New appointments at biopharma and equipment companies also feature in this week's column.
Pfizer’s UK MD, Jonathan Emms, has begun his post as President of the Association of the British Pharmaceutical Industry (ABPI), after his election at the end of last year.
He takes over from Deepak Khanna, MSD UK and will serve a one-year term before the next election.
Taking up the appointment, Emms said the pharmaceutical industry is facing several challenges at the moment.
“High barriers to getting innovative medicines to patients and low and slow usage across the NHS means we risk falling behind our European neighbours,” he said, adding he wanted to work with industry, government and the UK National Health Service (NHS) “to make change happen.”
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Welcome to in-PharmaTechnologist's monthly round up of who's been moving where in the small-molecule manufacturing world. The...
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...
The world’s largest modular cGMP biopharmaceutical manufacturing facility came online this week in Wuhan, China.
Valeant, Rentschler, Celgene, MannKind, and Syngene are among those welcoming new leaders for 2016. Oh, and Turing...